[--[65.84.65.76]--]
LUPIN
LUPIN LIMITED

1624.55 3.50 (0.22%)

Related News for LUPIN

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

 29 Feb 10:05 AM

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Lupin stock price up 0.09 per cent as Sensex slides

 28 Feb 10:56 AM

As of 31-Dec-2023, promoters held 46.76 per cent stake in the company, while FIIs held 16.11 per cent and domestic institutional investors had 18.92 per cent.

Share price of Lupin jumps as Sensex gains 167.65 points

 27 Feb 11:26 AM

A total of 11,967 shares changed hands on the counter till 11:26AM (IST)

Lupin shares drop 1.79% as Sensex falls

 26 Feb 12:22 PM

On the technical charts, the RSI of the stock stood at 59.64.

Holding 21,920 level can take Nifty higher: Analysts

 26 Feb 05:45 AM

Bajaj Finserv, Indus Towers, Inox India, Indian Hotels, ITC, Lupin, UltraTech Cement and HUL are some of the stocks that have formed bullish patterns on technical charts.

Sun Pharma, Lupin, Alkem recall products from US market

 25 Feb 08:06 PM

Sun Pharma is recalling 54,960 bottles of Mesalamine Extended-Release Capsules, an anti-inflammatory medicine used to treat a type of bowel disease known as ulcerative colitis

Lupin shares rise 1.23 per cent in Friday's trading session

 23 Feb 10:45 AM

The Relative Strength Index of the stock stood at 68.3 on Friday.

Buy Lupin, target price Rs 1770: Axis Securities

 23 Feb 09:31 AM

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.

Lupin declines 0.68% as Sensex slides

 22 Feb 01:03 PM

The stock traded at a P/E multiple of 40.44, while the price-to-book value ratio stood at 2.36.

Lupin declines 0.68% as Sensex slides

 22 Feb 01:03 PM

The stock traded at a P/E multiple of 40.44, while the price-to-book value ratio stood at 2.36.